HUMATIN  - paromomycin sulfate capsule 
Physicians Total Care, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DESCRIPTION

Humatin is a broad spectrum antibiotic produced by Streptomyces rimosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product supplied as capsules containing the equivalent of 250 mg paromomycin.

The capsule contains D&C yellow No. 10; FD&C blue No. 1; FD&C red No. 3; FD&C yellow No. 6; gelatin, NF; and titanium dioxide, USP.

ACTION

Corticosteroids are thought to act, at least in part, by controlling the rate of synthesis of proteins. Although there are a number of instances in which the

The in vitro and in vivo antibacterial action of paromomycin closely parallels that of neomycin. It is poorly absorbed after oral administration, with almost 100% of the drug recoverable in the stool.

INDICATIONS AND USAGE

Humatin is indicated for intestinal amebiasis––acute and chronic (NOTE ––It is not effective in extraintestinal amebiasis); management of hepatic coma––as adjunctive therapy.

CONTRAINDICATIONS

Paromomycin sulfate is contraindicated in individuals with a history of previous hypersensitivity reactions to it. It is also contraindicated in intestinal obstruction.

PRECAUTIONS

The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. Constant observation of the patient is essential. If new infections caused by nonsusceptible organisms appear during therapy, appropriate measures should be taken.

The drug should be used with caution in individuals with ulcerative lesions of the bowel to avoid renal toxicity through inadvertent absorption.

Pediatric Use: See Dosage and Administration section.

ADVERSE REACTIONS

Nausea, abdominal cramps, and diarrhea have been reported in patients on doses over 3 g daily.

DOSAGE AND ADMINISTRATION

Intestinal amebiasis: Adults and Pediatric Patients: Usual dose––25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days.

Management of hepatic coma: Adults: Usual dose––4 g daily in divided doses, given at regular intervals for five to six days.

HOW SUPPLIED

Humatin Capsules, each containing paromomycin sulfate equivalent to 250 mg paromomycin, are supplied as follows

NDC 54868-1562-1        Bottles of 100

Store at controlled room temperature 15°–30°C (59°–86°F).

Protect from moisture.

Rx only.

Prescribing Information as of November 2001.

Distributed by:
Monarch Pharmaceuticals, Inc., Bristol, TN 37620

Manufactured by:
Caraco Pharmaceutical Laboratories, Ltd., Detroit, MI 48202



Relabeling and Repackaging by:
Physicians Total Care, Inc.
Tulsa, OK     74146

PRINCIPAL DISPLAY PANEL - PACKAGE LABEL

Humatin

250 mg Capsules

image of No Label Available


HUMATIN 
paromomycin sulfate capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:54868-1562(NDC:61570-529)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PAROMOMYCIN SULFATE (PAROMOMYCIN) PAROMOMYCIN SULFATE250 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 
FD&C BLUE NO. 1 
FD&C RED NO. 3 
FD&C YELLOW NO. 6 
GELATIN 
TITANIUM DIOXIDE 
Product Characteristics
ColoryellowScore no score
ShapeCAPSULESize19mm
FlavorImprint Code ;
Contains    
Packaging
#Item CodePackage DescriptionMultilevel Packaging
1NDC:54868-1562-1100 CAPSULE ( CAPSULE) in 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other03/11/199405/31/2011

Labeler - Physicians Total Care, Inc. (194123980)
Establishment
NameAddressID/FEIOperations
Physicians Total Care, Inc.194123980relabel, repack

Revised: 07/2011 Physicians Total Care, Inc.